Patents by Inventor Rajendra G. Mehta

Rajendra G. Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods to prevent cancer with cupredoxins
    Patent number: 8158574
    Abstract: The present invention relates to compositions and methods comprising chemopreventive agents that may be cupredoxin(s) or variants, derivatives and structural equivalents of cupredoxins, and at least one other chemopreventive agent. Specifically, these compositions may comprise azurin from Pseudomonas aeruginosa, and/or the 50-77 residue region of azurin (p28). The at least one other chemopreventive agent may comprise an antiestrogen such as Tamoxifen. The compositions of the invention may be used to prevent the development of premalignant lesions in mammalian cells, tissues and animals, and thus prevent cancer.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: April 17, 2012
    Assignee: CDG Therapeutics, Inc.
    Inventors: Tapas Das Gupta, Rajendra G. Mehta, Rajeshwari Mehta, Craig Beattie
  • COMPOSITIONS AND METHODS TO PREVENT CANCER WITH CUPREDOXINS
    Publication number: 20090215692
    Abstract: The present invention relates to compositions and methods comprising chemopreventive agents that may be cupredoxin(s) or variants, derivatives and structural equivalents of cupredoxins, and at least one other chemopreventive agent. Specifically, these compositions may comprise azurin from Pseudomonas aeruginosa, and/or the 50-77 residue region of azurin (p28). The at least one other chemopreventive agent may comprise an antiestrogen such as Tamoxifen. The compositions of the invention may be used to prevent the development of premalignant lesions in mammalian cells, tissues and animals, and thus prevent cancer.
    Type: Application
    Filed: December 17, 2008
    Publication date: August 27, 2009
    Inventors: Tapas Das Gupta, Rajendra G. Mehta, Rajeshwari Mehta, Craig Beattie
  • 1?-Hydroxyvitamin D5, its synthesis and use in cancer prevention
    Patent number: 6900191
    Abstract: A compound of formula I: wherein R1 is hydrogen, R2 is —CH3, R3 is —CH3, and R4 is hydrogen, useful in cancer prevention and therapy.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: May 31, 2005
    Assignee: OncQuest, Inc.
    Inventors: Robert M. Moriarty, Raju A. Penmasta, Liang Guo, Munagala S. Rao, Rajendra G. Mehta